Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A



Status:Archived
Conditions:Hematology
Therapuetic Areas:Hematology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:November 2010
End Date:March 2013

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

ALONG: An Open-Label, Multicenter Evaluation of the Safety, Pharmacokinetics, and Efficacy of Recombinant Factor VIII Fc Fusion (rFVIIIFc) in the Prevention and Treatment of Bleeding in Previously Treated Subjects With Severe Hemophilia A


The study is to investigate safety, pharmacokinetics (the determination of the concentration
of drug in blood over time) and efficacy of Recombinant Factor VIII Fc Fusion (rFVIIIFc) in
previously treated subjects with severe hemophilia A



We found this trial at
4
sites
Clinical Trial Facility in Henderson Nevada
Henderson, Nevada
?
mi
from
Henderson, NV
Click here to add this to my saved trials
Clinical Trial Facility in Allentown Pennsylvania
Allentown, Pennsylvania
?
mi
from
Allentown, PA
Click here to add this to my saved trials
Clinical Trial Facility in Bellingham Washington
Bellingham, Washington
?
mi
from
Bellingham, WA
Click here to add this to my saved trials
Clinical Trial Facility in San Diego California
San Diego, California
?
mi
from
San Diego, CA
Click here to add this to my saved trials